N
Negin Hajizadeh
Researcher at Hofstra University
Publications - 62
Citations - 8376
Negin Hajizadeh is an academic researcher from Hofstra University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 12, co-authored 49 publications receiving 5867 citations. Previous affiliations of Negin Hajizadeh include The Feinstein Institute for Medical Research & New York University.
Papers
More filters
Journal ArticleDOI
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
Safiya Richardson,Safiya Richardson,Jamie S. Hirsch,Jamie S. Hirsch,Mangala Narasimhan,James M. Crawford,Thomas McGinn,Thomas McGinn,Karina W. Davidson,Karina W. Davidson,Douglas P. Barnaby,Douglas P. Barnaby,Lance B Becker,John Chelico,John Chelico,Stuart L. Cohen,Stuart L. Cohen,Jennifer Cookingham,Kevin Coppa,Michael A Diefenbach,Andrew J. Dominello,Joan Duer-Hefele,Louise Falzon,Jordan Gitlin,Negin Hajizadeh,Negin Hajizadeh,Tiffany G. Harvin,David Hirschwerk,Eun Ji Kim,Eun Ji Kim,Zachary Kozel,Lyndonna Marrast,Lyndonna Marrast,Jazmin N. Mogavero,Gabrielle A. Osorio,Michael Qiu,Theodoros P. Zanos +36 more
TL;DR: This case series provides characteristics and early outcomes of sequentially hospitalized patients with confirmed COVID-19 in the New York City area and assesses outcomes during hospitalization, such as invasive mechanical ventilation, kidney replacement therapy, and death.
Journal ArticleDOI
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series.
Janice Wang,Negin Hajizadeh,Ernest E. Moore,Robert C. McIntyre,Peter K. Moore,Livia A. Veress,Michael B. Yaffe,Michael B. Yaffe,Hunter B. Moore,Christopher D. Barrett,Christopher D. Barrett +10 more
TL;DR: A series of three patients with severe COVID‐19 respiratory failure who were treated with tissue plasminogen activator had a temporally related improvement in their respiratory status, with one of them being a durable response.
Journal ArticleDOI
Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm.
Sonali Narain,Dimitre G. Stefanov,Alice S. Chau,Andrew G. Weber,Galina Marder,Blanka Kaplan,Prashant Malhotra,Ona Bloom,Ona Bloom,Audrey Liu,Martin Lesser,Negin Hajizadeh,Negin Hajizadeh,Stuart L. Cohen,Jennifer Cookingham,David Hirschwerk,Naomi I Maria,Sanjaya K. Satapathy,Cristina Sison,Matthew D. Taylor,Michael Qiu +20 more
TL;DR: The combination of corticosteroid use either alone or in combination with tocilizumab or anakinra was associated with reduced hospital mortality for patients with COVID-19 cytokine storm compared to standard of care.
Journal ArticleDOI
Personalized estimates of benefit from preventive care guidelines: a proof of concept.
TL;DR: Models of personalized preventive care may illustrate how magnitude and rank order of benefit associated with preventive guidelines vary across recommendations and patients.
Journal ArticleDOI
The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.
Alice S. Chau,Andrew G. Weber,Naomi I Maria,Sonali Narain,Audrey Liu,Negin Hajizadeh,Prashant Malhotra,Ona Bloom,Galina Marder,Blanka Kaplan +9 more
TL;DR: Both parts of the immune system—innate and adaptive—play a significant role in the cytokine storm, multiorgan dysfunction, and coagulopathy of COVID‐19.